What psychiatric side effects can the antibiotic meropenem (brand name Ronem) cause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Psychiatric Side Effects of Meropenem (Ronem)

Meropenem can cause neuropsychiatric adverse effects including seizures, confusion, delirium, and rarely psychosis, though these occur in less than 1% of patients and are generally reversible upon drug discontinuation.

Key Psychiatric and Neurological Manifestations

The neuropsychiatric side effects associated with meropenem include 1:

  • Seizures - The most clinically significant CNS effect, though meropenem has a notably lower propensity for inducing seizures compared to other carbapenems like imipenem 2, 3, 4
  • Confusion and delirium
  • Anxiety and depression
  • Psychosis and mania (rare)
  • Headaches

Clinical Context and Risk Factors

Meropenem is actually the carbapenem of choice when CNS penetration is needed because it demonstrates better CNS tolerability than imipenem 2, 3. In clinical trials of bacterial meningitis, no patients experienced seizures after starting meropenem therapy, even at high doses up to 6g/day 3.

Important Risk Considerations:

  • Renal impairment increases risk of neurotoxicity due to drug accumulation
  • Pre-existing CNS disorders may predispose to neuropsychiatric effects
  • High cumulative doses increase risk
  • The overall incidence of neurotoxicity with antimicrobials is estimated at <1% 1

Recent Pharmacovigilance Data

A 2026 analysis of the FDA Adverse Event Reporting System identified meropenem-associated adverse events across multiple organ systems 5. While the analysis focused primarily on hematologic and systemic effects, neuropsychiatric signals were detected with:

  • Median time-to-onset of 5 days for adverse events
  • Early-onset clustering pattern (Weibull β = 0.72)
  • Higher reporting rates in patients aged 40-79 years

Clinical Management Algorithm

If psychiatric symptoms develop during meropenem therapy:

  1. Immediately assess for:

    • Renal function (creatinine clearance)
    • Electrolyte abnormalities
    • Concurrent medications that may lower seizure threshold
    • Underlying CNS pathology
  2. Discontinue meropenem - Most neurotoxic effects are reversible with drug withdrawal 1

  3. Provide supportive care and monitor closely

  4. Consider alternative antibiotics if continued therapy needed

Important Caveats

  • The provided FDA drug label 6 appears to be for ondansetron (an antiemetic), not meropenem, and is therefore not applicable to this question
  • Meropenem remains safer for CNS use than other carbapenems, making it the preferred agent when meningeal penetration is required 2, 3
  • Dose adjustment is essential in renal impairment to prevent drug accumulation and neurotoxicity
  • While psychiatric effects can occur, they are uncommon and typically resolve completely after discontinuation 1, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.